Clinical Trial Update: BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update notes completion of Phase 1/2 studies comparing BIOD-531 against Humalog Mix 75/25 and Humulin R U-500 for post-meal glucose control in ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• BIOD 531
• Humalog Mix 75/25 (insulin lispro protamine suspension and insulin lispro)
• Humulin R U-500 (insulin regular (human))

Snippet

Sponsor: Biodel | Conditions: Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED